Astrazeneca moved its global headquarters to Cambridge in 2016. Its new R&D facility in the centre of the Cambridge Biomedical Campus (CBC) will be an open, welcoming and vibrant centre that will inspire teamwork and partnerships to push the boundaries of scientific innovation.
Knight Asphalte worked with Mace to complete the PermaTEC and Permaphalt waterproofing on this landmark building that will be home to the bio science breakthroughs of the future.
Contractor: Mace Ltd acting for Astra Zeneca Plc
Product: PermaTEC & Permaphalt